Supporting this notion, our data demonstrate that SRSF9 acts as a pro‐hypertrophy protein, and knockdown of SRSF9 rescues TAC or Mettl1‐induced cardiac hypertrophy and remodeling. Here, METTL1 is linked to cardiac hypertrophy.